Heirloom Wealth Management Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Heirloom Wealth Management increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,500 shares of the healthcare conglomerate’s stock after buying an additional 277 shares during the period. UnitedHealth Group accounts for about 2.1% of Heirloom Wealth Management’s holdings, making the stock its 15th largest holding. Heirloom Wealth Management’s holdings in UnitedHealth Group were worth $5,528,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Axiom Financial Strategies LLC purchased a new stake in shares of UnitedHealth Group in the 1st quarter worth $210,000. McGowan Group Asset Management Inc. increased its stake in UnitedHealth Group by 8.9% in the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after acquiring an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after purchasing an additional 60,300 shares during the period. MAS Advisors LLC boosted its holdings in UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after acquiring an additional 45 shares during the period. Finally, First Western Trust Bank purchased a new position in UnitedHealth Group during the 1st quarter valued at $875,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Truist Financial reiterated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. Morgan Stanley lowered their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Piper Sandler increased their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Bank of America reiterated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock traded up $8.11 on Friday, reaching $501.29. The company had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The company’s fifty day moving average is $488.63 and its 200 day moving average is $515.13. The company has a market cap of $462.16 billion, a P/E ratio of 30.64, a PEG ratio of 1.31 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.